Reddit CEO: "Fairly Optimistic" We'll Get Net Neutrality Back
Reddit CEO Steve Huffman is “fairly optimistic” that actions will be taken to dial back the FCC’s repeal of net neutrality.
The head of the online news and content aggregator told Cheddar in an interview Tuesday, “I would be surprised if we lost regulations forever.”
Advocates of the Obama-era regulations have lobbied Congress to block the agency’s decision last week. And while the FCC’s vote went along party lines, with the three Republicans voting for repeal and the two Democrats voting against, Huffman doesn’t think legislators will follow the same path.
New York Senator Chuck Schumer, a Democrat, has called for a vote to overturn the repeal and Rep. Mike Coffman (R-CO) introduced a bill for permanent open internet to Congress.
Huffman told Cheddar that Reddit supports net neutrality and will continue to encourage users to make their voices heard in Congress.
“What matters the most is the opinion of the people,” he said. “When you look both in the United States in general and on Reddit specifically, there’s overwhelming support for this.”
For full interview [click here](https://cheddar.com/videos/reddits-plans-in-a-post-net-neutrality-world).
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
